230 related articles for article (PubMed ID: 25612239)
21. Medical treatment of early breast cancer. IV: neoadjuvant treatment.
Smith I; Chua S
BMJ; 2006 Jan; 332(7535):223-4. PubMed ID: 16439402
[No Abstract] [Full Text] [Related]
22. [Neoadjuvant systemic therapy in breast cancer].
Kahán Z; Nikolényi A; Uhercsák G; Thurzó L
Orv Hetil; 2009 Jan; 150(2):65-71. PubMed ID: 19103557
[TBL] [Abstract][Full Text] [Related]
23. Ipsilateral breast tumor recurrence (IBTR) in patients with operable breast cancer who undergo breast-conserving treatment after receiving neoadjuvant chemotherapy: risk factors of IBTR and validation of the MD Anderson Prognostic Index.
Ishitobi M; Ohsumi S; Inaji H; Ohno S; Shigematsu H; Akiyama F; Iwase T; Akashi-Tanaka S; Sato N; Takahashi K; Oura S
Cancer; 2012 Sep; 118(18):4385-93. PubMed ID: 22252882
[TBL] [Abstract][Full Text] [Related]
24. Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer.
Hieken TJ; Boughey JC; Jones KN; Shah SS; Glazebrook KN
Ann Surg Oncol; 2013 Oct; 20(10):3199-204. PubMed ID: 23846781
[TBL] [Abstract][Full Text] [Related]
25. Population based study on sentinel node biopsy before or after neoadjuvant chemotherapy in clinically node negative breast cancer patients: Identification rate and influence on axillary treatment.
van der Heiden-van der Loo M; de Munck L; Sonke GS; van Dalen T; van Diest PJ; van den Bongard HJ; Peeters PH; Rutgers EJ
Eur J Cancer; 2015 May; 51(8):915-21. PubMed ID: 25857549
[TBL] [Abstract][Full Text] [Related]
26. [Feasibility of breast conservation surgery after neoadjuvant chemotherapy for breast cancer].
Zhou B; Yang DQ; Qiao XM; Tong FZ; Cao YM; Liu P; Liu HJ
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):769-72. PubMed ID: 15949385
[TBL] [Abstract][Full Text] [Related]
27. Breast conservative surgery after neoadjuvant chemotherapy in breast cancer patients: comparison of two tumor localization methods.
Espinosa-Bravo M; Sao Avilés A; Esgueva A; Córdoba O; Rodriguez J; Cortadellas T; Mendoza C; Salvador R; Xercavins J; Rubio IT
Eur J Surg Oncol; 2011 Dec; 37(12):1038-43. PubMed ID: 21940138
[TBL] [Abstract][Full Text] [Related]
28. A multidisciplinary approach to neoadjuvant therapy for primary operable breast cancer. Challenges and opportunities.
Connolly R; Stearns V
Oncology (Williston Park); 2010 Feb; 24(2):135-43. PubMed ID: 20361464
[TBL] [Abstract][Full Text] [Related]
29. Recurrence rates after DCE-MRI image guided planning for breast-conserving surgery following neoadjuvant chemotherapy for locally advanced breast cancer patients.
Garimella V; Qutob O; Fox JN; Long ED; Chaturvedi A; Turnbull LW; Drew PJ
Eur J Surg Oncol; 2007 Mar; 33(2):157-61. PubMed ID: 17085007
[TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant bevacizumab: surgical complications of mastectomy with and without reconstruction.
Kansal KJ; Dominici LS; Tolaney SM; Isakoff SJ; Smith BL; Jiang W; Brock JE; Winer EP; Krop IE; Golshan M
Breast Cancer Res Treat; 2013 Sep; 141(2):255-9. PubMed ID: 24026859
[TBL] [Abstract][Full Text] [Related]
31. Breast conservation following neoadjuvant therapy for breast cancer in the modern era: Are we losing the opportunity?
Criscitiello C; Curigliano G; Burstein HJ; Wong S; Esposito A; Viale G; Giuliano M; Veronesi U; Santangelo M; Golshan M
Eur J Surg Oncol; 2016 Dec; 42(12):1780-1786. PubMed ID: 27825710
[TBL] [Abstract][Full Text] [Related]
32. Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy?
Daveau C; Stevens D; Brain E; Berges O; Villette S; Moisson P; Gardner M; De la Lande B; Lasry S; Labib A; Le Scodan R
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):337-42. PubMed ID: 20171795
[TBL] [Abstract][Full Text] [Related]
33. Rates of Neoadjuvant Chemotherapy and Oncoplastic Surgery for Breast Cancer Surgery: A French National Survey.
Clough KB; Acosta-Marín V; Nos C; Alran S; Rouanet P; Garbay JR; Giard S; Verhaeghe JL; Houvenaeghel G; Flipo B; Dauplat J; Dorangeon PH; Classe JM; Rouzier R; Bonnier P
Ann Surg Oncol; 2015 Oct; 22(11):3504-11. PubMed ID: 25665949
[TBL] [Abstract][Full Text] [Related]
34. Can breast MRI predict axillary lymph node metastasis in women undergoing neoadjuvant chemotherapy.
Javid S; Segara D; Lotfi P; Raza S; Golshan M
Ann Surg Oncol; 2010 Jul; 17(7):1841-6. PubMed ID: 20143266
[TBL] [Abstract][Full Text] [Related]
35. Surgical complications of skin sparing mastectomy and immediate prosthetic reconstruction after neoadjuvant chemotherapy for invasive breast cancer.
Donker M; Hage JJ; Woerdeman LA; Rutgers EJ; Sonke GS; Vrancken Peeters MJ
Eur J Surg Oncol; 2012 Jan; 38(1):25-30. PubMed ID: 21963981
[TBL] [Abstract][Full Text] [Related]
36. Pathologic complete response with six compared with three cycles of neoadjuvant epirubicin plus docetaxel and granulocyte colony-stimulating factor in operable breast cancer: results of ABCSG-14.
Steger GG; Galid A; Gnant M; Mlineritsch B; Lang A; Tausch C; Rudas M; Greil R; Wenzel C; Singer CF; Haid A; Pöstlberger S; Samonigg H; Luschin-Ebengreuth G; Kwasny W; Klug E; Kubista E; Menzel C; Jakesz R;
J Clin Oncol; 2007 May; 25(15):2012-8. PubMed ID: 17513805
[TBL] [Abstract][Full Text] [Related]
37. [Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy].
Straver ME; van Adrichem JC; Rutgers EJ; Rodenhuis S; Linn SC; Loo CE; Gilhuijs KG; Oldenburg HS; Wesseling J; Russell NS; Antonini N; Vrancken Peeters MT
Ned Tijdschr Geneeskd; 2008 Nov; 152(46):2519-25. PubMed ID: 19055260
[TBL] [Abstract][Full Text] [Related]
38. The timing of breast and axillary surgery after neoadjuvant chemotherapy for breast cancer.
Al-Hilli Z; Boughey JC
Chin Clin Oncol; 2016 Jun; 5(3):37. PubMed ID: 27164853
[TBL] [Abstract][Full Text] [Related]
39. Influence of neoadjuvant chemotherapy on HER2/neu status in invasive breast cancer.
Li P; Liu T; Wang Y; Shao S; Zhang W; Lv Y; Yi J; Wang Z
Clin Breast Cancer; 2013 Feb; 13(1):53-60. PubMed ID: 23103368
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast.
Botti C; Vici P; Lopez M; Scinto AF; Cognetti F; Cavaliere R
J Am Coll Surg; 1995 Sep; 181(3):202-8. PubMed ID: 7670678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]